Skip to main content

ARYA Sciences Acquisition Corp. IV (ARYD)

NASDAQ: ARYD · IEX Real-Time Price · USD
9.94 -0.01 (-0.10%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap195.67M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out15.45M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,009
Open9.94
Previous Close9.95
Day's Range9.86 - 9.95
52-Week Range9.73 - 12.38
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ARYD

ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

IndustryShell Companies
IPO DateFeb 26, 2021
Stock ExchangeNASDAQ
Ticker SymbolARYD
Full Company Profile

News

ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering

ARYA Sciences Acquisition Corp IV (the “Company”), a special purpose acquisition company formed for the...

6 months ago - GlobeNewswire

Perceptive Advisors' fourth SPAC ARYA Sciences Acquisition IV files for a $130 million IPO

ARYA Sciences Acquisition IV, the fourth healthcare-focused blank check company formed by Perceptive Advisors, filed on Wednesday with the SEC to raise up to $130 million in an initial public offering.

7 months ago - NASDAQ

ARYA Sciences Acquisition IV IPO Registration Document (S-1)

ARYA Sciences Acquisition Corp. IV has filed to go public with an IPO on the NASDAQ.

7 months ago - SEC